Adeshwar Meditex Limited (BOM:543309)
India
· Delayed Price · Currency is INR 15.45
0.00 (0.00%)
At close: Apr 29, 2026
Adeshwar Meditex Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2018 |
| Operating Revenue | 728.75 | 837.13 | 798.5 | 823.57 | 647.55 | 659.72 | Upgrade
|
| Revenue | 728.75 | 837.13 | 798.5 | 823.57 | 647.55 | 659.72 | Upgrade
|
| Revenue Growth (YoY) | -2.16% | 4.84% | -3.04% | 27.18% | -1.84% | 17.56% | Upgrade
|
| Cost of Revenue | 630.21 | 746.14 | 700.38 | 700.77 | 550.74 | 547.82 | Upgrade
|
| Gross Profit | 98.54 | 90.99 | 98.12 | 122.8 | 96.82 | 111.9 | Upgrade
|
| Selling, General & Admin | 28.87 | 21.96 | 17.65 | 21.06 | 21.52 | 24.23 | Upgrade
|
| Other Operating Expenses | 29.26 | 22.44 | 27.16 | 47.25 | 39.45 | 37.55 | Upgrade
|
| Operating Expenses | 62.78 | 49.39 | 50.82 | 73.63 | 64.8 | 65.46 | Upgrade
|
| Operating Income | 35.77 | 41.6 | 47.3 | 49.17 | 32.02 | 46.44 | Upgrade
|
| Interest Expense | -8.77 | -12.21 | -17.21 | -19.53 | -19.39 | -21.2 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.28 | 0.28 | -0.19 | 0.76 | 0.41 | 1.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.72 | -1.72 | -2.05 | -1.36 | -1.13 | -1.73 | Upgrade
|
| EBT Excluding Unusual Items | 25.55 | 27.93 | 27.85 | 29.04 | 11.91 | 24.62 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -1.21 | Upgrade
|
| Pretax Income | 25.55 | 27.93 | 27.85 | 29.04 | 11.91 | 23.41 | Upgrade
|
| Income Tax Expense | 6.63 | 7.28 | 7.77 | 8.3 | 3.98 | 6.63 | Upgrade
|
| Net Income | 18.93 | 20.66 | 20.08 | 20.74 | 7.93 | 16.77 | Upgrade
|
| Net Income to Common | 18.93 | 20.66 | 20.08 | 20.74 | 7.93 | 16.77 | Upgrade
|
| Net Income Growth | -13.40% | 2.87% | -3.19% | 161.58% | -52.73% | -20.73% | Upgrade
|
| Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 11 | Upgrade
|
| Shares Change (YoY) | 0.57% | - | - | - | 37.03% | 2.25% | Upgrade
|
| EPS (Basic) | 1.31 | 1.43 | 1.39 | 1.44 | 0.55 | 1.59 | Upgrade
|
| EPS (Diluted) | 1.31 | 1.43 | 1.39 | 1.44 | 0.55 | 1.59 | Upgrade
|
| EPS Growth | -13.91% | 2.88% | -3.29% | 161.58% | -65.44% | -22.44% | Upgrade
|
| Free Cash Flow | 31.11 | 36.51 | 34.09 | 57.67 | -36.07 | 28.28 | Upgrade
|
| Free Cash Flow Per Share | 2.16 | 2.53 | 2.36 | 4.00 | -2.50 | 2.69 | Upgrade
|
| Gross Margin | 13.52% | 10.87% | 12.29% | 14.91% | 14.95% | 16.96% | Upgrade
|
| Operating Margin | 4.91% | 4.97% | 5.92% | 5.97% | 4.95% | 7.04% | Upgrade
|
| Profit Margin | 2.60% | 2.47% | 2.51% | 2.52% | 1.22% | 2.54% | Upgrade
|
| Free Cash Flow Margin | 4.27% | 4.36% | 4.27% | 7.00% | -5.57% | 4.29% | Upgrade
|
| EBITDA | 40.42 | 46.59 | 53.31 | 54.48 | 35.84 | 50.12 | Upgrade
|
| EBITDA Margin | 5.55% | 5.56% | 6.68% | 6.62% | 5.54% | 7.60% | Upgrade
|
| D&A For EBITDA | 4.65 | 4.99 | 6.01 | 5.31 | 3.82 | 3.68 | Upgrade
|
| EBIT | 35.77 | 41.6 | 47.3 | 49.17 | 32.02 | 46.44 | Upgrade
|
| EBIT Margin | 4.91% | 4.97% | 5.92% | 5.97% | 4.95% | 7.04% | Upgrade
|
| Effective Tax Rate | 25.93% | 26.05% | 27.91% | 28.59% | 33.43% | 28.33% | Upgrade
|
| Revenue as Reported | 729.76 | 839.72 | 799.83 | 826.63 | 649.84 | 662.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.